J.S.W. Stewart

2.7k total citations
36 papers, 2.1k citations indexed

About

J.S.W. Stewart is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.S.W. Stewart has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.S.W. Stewart's work include Radiopharmaceutical Chemistry and Applications (11 papers), Head and Neck Cancer Studies (8 papers) and RNA Interference and Gene Delivery (7 papers). J.S.W. Stewart is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Head and Neck Cancer Studies (8 papers) and RNA Interference and Gene Delivery (7 papers). J.S.W. Stewart collaborates with scholars based in United Kingdom, United States and Netherlands. J.S.W. Stewart's co-authors include Kevin J. Harrington, Paul S. Uster, A. M. Peters, R G Vile, S. Mohammadtaghi, Daphne M. Glass, Gail Rowlinson‐Busza, Konstantinos N. Syrigos, Susan E. Krown and David Osoba and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

J.S.W. Stewart

36 papers receiving 2.1k citations

Peers

J.S.W. Stewart
Leslie Tupchong United States
Aron Popovtzer Israel
George P. Stathopoulos Greece
Si Yeol Song South Korea
Guido Piontek Germany
D G Kieback United States
Jung Shin Lee South Korea
Willem M. L. L. G. Deserno Netherlands
Melissa Walker United States
Olav Kaalhus Norway
Leslie Tupchong United States
J.S.W. Stewart
Citations per year, relative to J.S.W. Stewart J.S.W. Stewart (= 1×) peers Leslie Tupchong

Countries citing papers authored by J.S.W. Stewart

Since Specialization
Citations

This map shows the geographic impact of J.S.W. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.S.W. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.S.W. Stewart more than expected).

Fields of papers citing papers by J.S.W. Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.S.W. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.S.W. Stewart. The network helps show where J.S.W. Stewart may publish in the future.

Co-authorship network of co-authors of J.S.W. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of J.S.W. Stewart. A scholar is included among the top collaborators of J.S.W. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.S.W. Stewart. J.S.W. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stewart, J.S.W., Ezra E.W. Cohen, Lisa Licitra, et al.. (2009). Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology. 27(11). 1864–1871. 267 indexed citations
3.
Stewart, J.S.W., Ezra E.W. Cohen, Lisa Licitra, et al.. (2007). A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck. Cancer Research. 67. 3522–3522. 18 indexed citations
4.
Krown, Susan E., Donald W. Northfelt, David Osoba, & J.S.W. Stewart. (2004). Use of liposomal anthracyclines in Kaposi’s sarcoma. Seminars in Oncology. 31(6 Suppl 13). 36–52. 117 indexed citations
5.
Harrington, Kevin J., et al.. (2004). Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model. British Journal of Cancer. 91(2). 366–373. 11 indexed citations
6.
Harrington, Kevin J., Gail Rowlinson‐Busza, Konstantinos N. Syrigos, et al.. (2001). The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes. International Journal of Radiation Oncology*Biology*Physics. 50(3). 809–820. 11 indexed citations
7.
Harrington, Kevin J., Gail Rowlinson‐Busza, Paul S. Uster, et al.. (2001). Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model. International Journal of Radiation Oncology*Biology*Physics. 49(4). 1141–1148. 11 indexed citations
8.
Harrington, Kevin J., et al.. (2001). Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer. Annals of Oncology. 12(4). 493–496. 149 indexed citations
9.
Harrington, Kevin J., Gail Rowlinson‐Busza, Konstantinos N. Syrigos, et al.. (2000). Influence of tumour size on uptake of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model. British Journal of Cancer. 83(5). 684–688. 74 indexed citations
10.
Harrington, Kevin J., Gail Rowlinson‐Busza, Konstantinos N. Syrigos, et al.. (2000). Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. British Journal of Cancer. 83(2). 232–238. 76 indexed citations
11.
Harrington, Kevin J., Gail Rowlinson‐Busza, Paul S. Uster, & J.S.W. Stewart. (2000). Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours. Cancer Chemotherapy and Pharmacology. 46(1). 10–18. 26 indexed citations
12.
Harrington, Kevin J., et al.. (2000). Liposomes as Vehicles for Targeted Therapy of Cancer. Part 2: Clinical Development. Clinical Oncology. 12(1). 16–24. 50 indexed citations
13.
Harrison, Mark, Kevin J. Harrington, David R. Tomlinson, & J.S.W. Stewart. (1998). Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiotherapy and Oncology. 46(1). 23–28. 25 indexed citations
14.
Goldstein, David, et al.. (1996). Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. British Journal of Cancer. 73(8). 989–994. 85 indexed citations
15.
Maraveyas, Anthony, N. Stafford, Gail Rowlinson‐Busza, J.S.W. Stewart, & A. A. Epenetos. (1995). Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.. PubMed. 55(5). 1060–9. 10 indexed citations
16.
James, Nicholas D., R J Coker, David R. Tomlinson, et al.. (1994). Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS. Clinical Oncology. 6(5). 294–296. 158 indexed citations
17.
Maraveyas, Anthony, M J Myers, J.S.W. Stewart, & A. A. Epenetos. (1994). 46. Local tissue radiation dose in combined radiolabelled antibody and external radiotherapy treatment (RAcER) for head and neck cancer. Nuclear Medicine Communications. 15(4). 236–236. 1 indexed citations
18.
James, Nicholas D. & J.S.W. Stewart. (1991). Kaposi's Sarcoma and AIDS. International Journal of STD & AIDS. 2(2). 91–96. 2 indexed citations
19.
Stewart, J.S.W., V Hird, D Snook, et al.. (1989). Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies. International Journal of Radiation Oncology*Biology*Physics. 16(2). 405–413. 88 indexed citations
20.
Stewart, J.S.W., et al.. (1989). AIDS: Incidence and management of malignant disease. Radiotherapy and Oncology. 14(2). 121–131. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie Tupchong Breakdown of academic impact, for papers by Aron Popovtzer Breakdown of academic impact, for papers by George P. Stathopoulos Breakdown of academic impact, for papers by Si Yeol Song Breakdown of academic impact, for papers by Guido Piontek Breakdown of academic impact, for papers by D G Kieback Breakdown of academic impact, for papers by Jung Shin Lee Breakdown of academic impact, for papers by Willem M. L. L. G. Deserno Breakdown of academic impact, for papers by Melissa Walker Breakdown of academic impact, for papers by Olav Kaalhus
Rankless by CCL
2026